Close Menu

NEW YORK – Philadelphia-based startup Group K Diagnostics and laboratory medicine service firm Health Network Laboratories said today that they are collaborating in a clinical trial to validate the accuracy, effectiveness, and clinical implications of GKD's MultiNostic liver function test.

Clinical trial investigators will also analyze the impact of the microfluidic point-of-care test on operational efficiencies, GKD said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.